MoneyWorks4Me

Senores Pharmaceutic - Quaterly Results

23 Jan 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 95.90 millions grew by 7.63 % from Rs. 89.10 millions.The Total revenue for the quarter ended December 2024 of  Rs. 10.70  millions  grew by 435.00% from Rs. 2.00 millions.Operating profit surged to 47.70 millions from the corresponding previous quarter of 16.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202412 202312 % Var
Sales 95.90 89.10 7.63 95.90 89.10 7.63 95.90 89.10 7.63
Other Income 71.90 21.50 234.42 71.90 21.50 234.42 71.90 21.50 234.42
PBIDT 47.70 16.20 194.44 47.70 16.20 194.44 47.70 16.20 194.44
Interest 27.00 6.70 302.99 27.00 6.70 302.99 27.00 6.70 302.99
PBDT 20.70 9.50 117.89 20.70 9.50 117.89 20.70 9.50 117.89
Depreciation 7.50 4.60 63.04 7.50 4.60 63.04 7.50 4.60 63.04
PBT 13.20 4.90 169.39 13.20 4.90 169.39 13.20 4.90 169.39
TAX 2.50 2.90 -13.79 2.50 2.90 -13.79 2.50 2.90 -13.79
Deferred Tax -0.30 0.20 -250.00 -0.30 0.20 -250.00 -0.30 0.20 -250.00
PAT 10.70 2.00 435.00 10.70 2.00 435.00 10.70 2.00 435.00
Equity 460.50 299.50 53.76 460.50 299.50 53.76 460.50 299.50 53.76
PBIDTM(%) 49.74 18.18 173.57 49.74 18.18 173.57 49.74 18.18 173.57
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..